Genome profiling of acute myelomonocytic leukemia: alteration of the MYB locus in MYST3-linked cases-Reference-Cited by-同舟云学术

Genome profiling of acute myelomonocytic leukemia: alteration of the MYB locus in MYST3-linked cases

Published:2008-09-25 Issue:1 Volume:23 Page:85-94
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Murati A, ,Gervais C,Carbuccia N,Finetti P,Cervera N,Adélaïde J,Struski S,Lippert E,Mugneret F,Tigaud I,Penther D,Bastard C,Poppe B,Speleman F,Baranger L,Luquet I,Cornillet-Lefebvre P,Nadal N,Nguyen-Khac F,Pérot C,Olschwang S,Bertucci F,Chaffanet M,Lessard M,Mozziconacci M-J,Birnbaum D

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2008257.pdf

Reference50 articles.

1. Aguiar RC, Chase A, Coulthard S, Macdonald DH, Carapeti M, Reiter A et al. Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement. Blood 1997; 90: 3130–3135.

2. Borrow J, Stanton Jr VP, Andresen JM, Becher R, Behm FG, Chaganti RS et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 1996; 14: 33–41.

3. Giles RH, Dauwerse JG, Higgins C, Petrij F, Wessels JW, Beverstock GC et al. Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16). Leukemia 1997; 11: 2087–2096.

4. Chaffanet M, Gressin L, Preudhomme C, Soenen-Cornu V, Birnbaum D, Pébusque MJ . MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). Genes Chromosomes Cancer 2000; 28: 138–144.

5. Murati A, Adélaide J, Mozziconacci MJ, Popovici C, Carbuccia N, Letessier A et al. Variant MYST4-CBP gene fusion in a t(10;16) acute myeloid leukaemia. Br J Haematol 2004; 125: 601–604.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML;Cell Death & Disease;2023-11-23

2. Discovery of N-(2-oxoethyl) sulfanilamide-derived inhibitors of KAT6A (MOZ) against leukemia by an isostere strategy;European Journal of Medicinal Chemistry;2023-11

3. The role of MOZ/KAT6A in hematological malignancies and advances in MOZ/KAT6A inhibitors;Pharmacological Research;2021-12

4. A large co‐operative biological and clinical study to better understand and improve treatment of the rare t(8;16)(p11;p13) acute myeloid leukaemia;British Journal of Haematology;2021-02-04

5. Uncommon cytogenetic abnormalities identifying high-risk acute myeloid leukemia in children;Future Oncology;2020-11